Table 1 Group characteristics
From: Blood molybdenum level as a marker of cancer risk on BRCA1 carriers
N = 989 | |
|---|---|
Age at enrollment | |
< 50 years ≥ 50 years | 775 (78.36%) 214 (21.64%) |
Smoking | |
never ever missing data | 720 (72.80%) 264 (26.70%) 5 (0.50%) |
Hormonal therapy | |
never ever missing data | 720 (72.80%) 263 (26.59%) 6 (0.61%) |
Oophorectomy | |
no yes missing data | 413 (41.89%) 573 (58.11%) 0 (0.00%) |
Oral Contraceptive use | |
never ever missing data | 501 (50.51%) 481 (48.28%) 6 (1.21%) |
Body Mass Index (kg/m2) | |
< 18.5 18.5–24.9 25.0-29.9 ≥ 30.0 -missing data | 56 (5.66%) 553 (55.92%) 237 (23.96%) 95 (9.61%) 48 (4.85%) |
New cancer site | |
breast ovarian bladder cervix colon kidney leukemia lung pancreas salivary gland sarcoma site unknown skin thyroid urothelial | 121 (69.94%) 29 (16.75%) 2 (1.16%) 3 (1.73%) 2 (1.16%) 1 (0.58%) 2 (1.16%) 3 (1.73%) 1 (0.58%) 1 (0.58%) 1 (0.58%) 1 (1.16%) 1 (0.58%) 3 (1.73%) 1 (0.58%) |